ArticleInternational journal of molecular sciences2022

Preclinical Evaluation of CRISPR-Edited CAR-NK-92 Cells for Off-the-Shelf Treatment of AML and B-ALL.

Guillermo Ureña-Bailén et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.